stock-detail (EPZM)

Oncology Corporate Profile

Company Description

This company does not have any commercial products

This company does not have any pipeline products

Recent News Headlines

4/23/2017 12:17 pm

4/23/2017 12:17 pm

4/23/2017 12:17 pm

4/23/2017 12:17 pm

4/23/2017 12:17 pm

4/20/2017 06:17 am

4/20/2017 06:17 am

4/20/2017 06:17 am

4/20/2017 06:17 am

4/20/2017 06:17 am

4/14/2017 06:17 am

4/14/2017 06:17 am

4/14/2017 06:17 am

4/14/2017 06:17 am

4/14/2017 06:17 am

4/10/2017 06:17 am

4/10/2017 06:17 am

4/10/2017 06:17 am

4/10/2017 06:17 am

4/10/2017 06:17 am

4/7/2017 12:17 pm

Epizyme to Present New Preclinical Data on Tazemetostat and Epigenetic Target Identification Efforts at AACR Annual Meeting

3/29/2017 10:03 am

[GlobeNewswire] - CAMBRIDGE, Mass., March 29, 2017-- Epizyme, Inc., a clinical-stage biopharmaceutical company creating novel epigenetic therapies, today announced that new preclinical data on tazemetostat, Epizyme’ s lead ...

EPIZYME, INC. Financials

3/16/2017 05:00 pm